I think that there is more research out there, and what I have read indicates that PM has an anti-proliferative effect on multiple breast cancer lines as well some gynecological cancer cell lines. I did come across the report Isabelle quoted which was done 2004. There has been more research by those and other folks in the far east, which unfortunately, is often overlooked by western medicine. Specifically I found a 2005 study that concluded:
These re- sults suggest that phytoestrogens derived from Pue- raria root could be used as a natural alternative to estrogen, offering a lower risk of gynecological cancer when ERT is considered to alleviate the symptoms of menopause. Moreover, the phytoestrogens could be used as a chemopreventive agent in some gy- necological cancers.
http://www.onius.net/downloads/EMM037-02-06.pdf
Another study in 2007 sought to answer Isabelle's question about what happens at concentrations between 1 microgram/ml and 1000 micrograms/ml. They concluded:
the P. mirifica population exhibited cytotoxic effects at concentrations of 100 micrograms/ml and 1000 micrograms/ml.
http://www.jstage.jst.go.jp/article/jrd/54/1/63/_pdf
Also, because they used two types of estrogenic activity assays, they further concluded that simply looking at in vitro analysis (using the MCF-7 assay) may lead one to potentially false conclusions about the effects of PM on in vivo cells. There is other research (cited in their study) that suggests there is a metabolic activation required for many of the compounds in PM that will affect outcomes of different in vivo assays (rat vaginal cell cornification estrogenic activity assay.) The original 2004 study, only looked at plants from one region of Thailand, at limited dosage concentrations, and using an in vitro assay (MCF-7 cell line.)
Another 2007 study demonstrated:
Pretreatment of 1000 mg/(kg BW day) of P. mirifica tuberous powder resulted in decreasing of the virulence of rat tumor development. The mammary tumor tissues exhibited lower profile of ERα and ERβ as well as ERα/ERβ.
http://www.sciencedirect.com/science/art...220700240X
And a further 2008 study revealed:
At P100 and P1000, bone loss was completely prevented both in trabecular bone mineral density and content. The effects of P. mirifica were, as expected, comparable to that in the EE group.
http://www.sciencedirect.com/science/art...2208000297
(Note: EE group above refers treatment with 17-alpha-ethinylestradiol, analogous to routine HRT)
I only did a relatively cursory survey of the 149 hits I got on
www.scholar.google.com for the search string: "pueraria mirifica and breast cancer. I would guess that an in depth study of all of those citations (some would be related to the search string but not yield studies such as those above) would probably yield similar conclusions, with the main one being PM in vivo has a protective effect on breast cancer and other sequelae related to menopause.
Just my opinion of course. Hope this helps.
chrishoney